Boston Scientific Showcases Peripheral and Oncology Intervention Innovations at 2022 Oriental International Interventional Medicine Expo

ShanghaiJanuary 12, 2023PR Newswire -- December 29, 2022 - December 31, 2022: The first Oriental International Interventional Medicine Expo (Interventional Expo) was successfully held at the Shanghai World Expo Exhibition Center. As an integrated innovative communication platform for the interventional treatment field to promote "new technologies, new concepts, and new devices," the Interventional Expo attracted participation from multiple well-known medical institutions and industry enterprises in China.

Boston ScientificAs one of the leading pioneers in the field of peripheral and oncological intervention both in China and globally, Boston Scientific Corporation always aims for the complete recovery of patients as the ultimate goal and prioritizes the safety of doctors' diagnosis and treatment. It actively promotes technical training and education in peripheral vascular interventional therapy, extracranial neurovascular interventional therapy, tumor vascular embolization, non-vascular minimally invasive interventional drainage, and radiofrequency treatment. It provides Chinese doctors and patients with the most suitable treatment solutions and product services. Since entering China, the Peripheral and Oncology Intervention Division has been actively sharing its expertise and experience in the management of critical and chronic diseases, benefiting patients across the country.

This Appearance2022 Oriental International Interventional Medicine ExpoBoston Scientific brings seven solutions in the field of peripheral and oncology interventional diagnosis and treatment, sharing cutting-edge innovative technologies with medical professionals and patients in China.

Boston Scientific Booth @IMworld2022

(From the right) Professor Ge Junbo, Lifetime Honorary Chairman of the CIIE; Professor Fan Daiming, Honorary Chairman of the CIIE; and Professor Li Maoquan, Chairman of the CIIE and President of IMIA, visit the Boston Scientific booth for guidance.

Among the many products showcased at the Boston Scientific booth, the star products that highlight Boston Scientific's "black technology" are the Eluvia Nitinol Paclitaxel-Eluting Vascular Stent and DC Bead.^®These two products, embolic microspheres.

Eluvia, as the world's first polymer-coated peripheral arterial drug-eluting stent, truly achieves a drug release duration that fully covers the peak period of restenosis after stent implantation. It has been nominated for the 16th Annual Galien USA Awards. Known as the "Nobel Prize of the pharmaceutical industry," the Galien Award is the highest recognized honor in the fields of medicine and pharmaceuticals, aiming to commend outstanding research and innovation in medical science.

DC Bead^®Embolization microspheres are uniform in size, have a small particle diameter, and provide excellent tumor coverage. They are mainly used in transarterial chemoembolization (TACE), which is widely applied in the interventional treatment of liver cancer. The treatment principle involves injecting embolization microspheres into the tumor via the hepatic artery, blocking the blood vessels that supply the tumor while precisely delivering chemotherapy locally. This reduces adverse reactions and improves the patient's quality of life.

Boston Scientific Corporation is committed to innovation for life. We are dedicated to innovative medical solutions that improve the lives of patients worldwide. For over three decades, Boston Scientific has consistently led the global medical technology industry by delivering a wide range of high-performance medical solutions that meet critical patient needs and reduce healthcare costs.

At the closing ceremony, Li Maoquan, Chairman of the Jiebo Fair, announced that the 2nd Oriental International Interventional Medicine Expo will be held from October 12 to 15, 2023. The National Clinical Medical Center for Radiology and Treatment 2023 Annual Conference, the 2023 National Interventional Medicine Innovation Alliance Annual Meeting, the 2023 China Interventional Medicine Materials and Engineering Forum, and the 10th Diabetic Foot Cells and Interventional Treatment Academic Conference will also take place during the same period. Looking forward to meeting again!